These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15702834)

  • 1. MIB1 proliferation index in meningiomas: does it predict recurrence? A clinicopathological study.
    Tyagi A; Chakrabarty A; Franks A
    Br J Neurosurg; 2004 Aug; 18(4):357-61. PubMed ID: 15702834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of candidate immunohistochemical prognostic markers of meningioma recurrence.
    Csonka T; Murnyák B; Szepesi R; Bencze J; Bognár L; Klekner A; Hortobágyi T
    Folia Neuropathol; 2016; 54(2):114-26. PubMed ID: 27543769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to Recurrence of Intracranial Meningiomas from a Monoinstitutional Surgical Series.
    Maiuri F; Corvino S; Corazzelli G; Berardinelli J; Di Crescenzo RM; Del Basso De Caro M
    World Neurosurg; 2024 May; 185():e612-e619. PubMed ID: 38417623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki-67 index as a predictive marker of meningioma recurrence following surgical resection.
    Mizrachi M; Hartley B; Saleem S; Hintz E; Ziemba Y; Li J; Goenka A; Schulder M
    J Clin Neurosci; 2024 Jun; 124():15-19. PubMed ID: 38631196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management.
    Ohta M; Iwaki T; Kitamoto T; Takeshita I; Tateishi J; Fukui M
    Cancer; 1994 Dec; 74(12):3176-89. PubMed ID: 7982181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
    Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
    Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II.
    Prat-Acín R; Guarín-Corredor MJ; Galeano-Senabre I; Ayuso-Sacido A; Vera-Sempere F
    J Clin Neurosci; 2021 Apr; 86():32-37. PubMed ID: 33775343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single versus multiple reoperations for recurrent intracranial meningiomas.
    Maiuri F; Corvino S; Corazzelli G; Del Basso De Caro M
    J Neurooncol; 2024 Jul; 168(3):527-535. PubMed ID: 38656725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of histological signs of tumor progression in recurrences of completely resected meningiomas.
    Schiffer D; Ghimenti C; Fiano V
    J Neurooncol; 2005 Jun; 73(2):125-30. PubMed ID: 15981101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors.
    Maiuri F; De Caro MB; Esposito F; Cappabianca P; Strazzullo V; Pettinato G; de Divitiis E
    J Neurooncol; 2007 Mar; 82(1):63-8. PubMed ID: 17225937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary resected meningiomas: relapses and proliferation markers.
    Kalala JP; Caemaert J; De Ridder L
    In Vivo; 2004; 18(4):411-6. PubMed ID: 15369177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting post-operative recurrence or growth of meningiomas, other than histological grade and extent of resection.
    Quddusi A; Virani QU; Shamim MS
    J Pak Med Assoc; 2019 Oct; 69(10):1570-1571. PubMed ID: 31622321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA topoisomerase IIalpha expression correlates with cell proliferation but not with recurrence in intracranial meningiomas.
    Konstantinidou AE; Patsouris E; Korkolopoulou P; Kavantzas N; Mahera H; Davaris P
    Histopathology; 2001 Oct; 39(4):402-8. PubMed ID: 11683942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can recurrence of meningiomas be predicted?
    Kalala JP; Benoit D; De Ridder L
    Anticancer Res; 2004; 24(4):2319-24. PubMed ID: 15330178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics.
    Kolles H; Niedermayer I; Schmitt C; Henn W; Feld R; Steudel WI; Zang KD; Feiden W
    Acta Neurochir (Wien); 1995; 137(3-4):174-81. PubMed ID: 8789658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of apparent diffusion coefficient with Ki-67 proliferation index in grading meningioma.
    Tang Y; Dundamadappa SK; Thangasamy S; Flood T; Moser R; Smith T; Cauley K; Takhtani D
    AJR Am J Roentgenol; 2014 Jun; 202(6):1303-8. PubMed ID: 24848829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.
    Oya S; Kawai K; Nakatomi H; Saito N
    J Neurosurg; 2012 Jul; 117(1):121-8. PubMed ID: 22559847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCNA, Ki-67 and hTERT in residual benign meningiomas.
    Maes L; Kalala JP; Cornelissen M; De Ridder L
    In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracranial meningiomas: analysis of recurrence after surgical treatment.
    Mahmood A; Qureshi NH; Malik GM
    Acta Neurochir (Wien); 1994; 126(2-4):53-8. PubMed ID: 8042555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.